ESMOLOL HYDROCHLORIDE (ess'moe-lol) Brevibloc Classifications: autonomic nervous system agent; beta-adrenergic antagonist (blocking agent, sympatholytic) Prototype: Propranolol Pregnancy Category: C |
10 mg/mL, 250 mg/mL injection
Ultrashort-acting beta1-adrenergic blocking agent with cardioselective properties but devoid of intrinsic sympathetic activity (ISA) or membrane-stabilizing (quinidine-like) activity. Hemodynamic effects are mild, with potency as a beta blocker about 1/100 that of propranolol. Inhibits the agonist effect of catecholamines by competitive binding at beta-adrenergic receptors.
Blocks sympathetically mediated increases in cardiac rate and BP since it binds predominantly to beta1-receptors in cardiac tissue.
Supraventricular tachyarrhythmias (SVT) in perioperative and postoperative periods or in other critical situations. Also short-term treatment of noncompensating sinus tachycardia and in the control of heart rate for patients with MI.
Moderate postoperative hypertension; treatment of intense transient adrenergic response to surgical stress in cardiac as well as noncardiac surgery.
Cardiac failure, heart block greater than first degree, sinus bradycardia, cardiogenic shock; pregnancy (category C), lactation. Safety in children is not established.
History of allergy or bronchial asthma, bronchospasm, emphysema; CHF; diabetes mellitus; kidney function impairment.
Supraventricular Tachyarrhythmias Adult: IV 500 mcg/kg loading dose followed by 50 mcg/kg/min, may increase dose q510min prn (max: 200 mcg/kg/min) |
Intravenous PREPARE: Direct: Use the 10 mg/mL vial undiluted for the loading dose. IV Infusion: Prepare maintenance infusion by adding 250 mL of diluent to each 2500 mg ampul to yield 10 mg/mL. Compatible diluents include D5W, D5/RL, D5/NS, D5/.45NS, RL. ADMINISTER: Direct: Give loading dose over 1 min. IV Infusion: Give maintenance infusion over 4 min. If adequate response is noted, continue maintenance infusion with periodic adjustments as needed. If an adequate response has not occurred, repeat loading dose and follow with an increased maintenance infusion of 100 mcg/kg/min. May continue titration cycle with same loading dose while increasing maintenance infusion by 50 mcg/kg/min until desired end point is near. Then omit loading dose and titrate maintenance dose up or down by 25 to 50 mcg/kg/min until desired heart rate is reached. INCOMPATIBILITIES Solution/Additive: Procainamide. Y-site: Amphotericin B cholesteryl, furosemide, warfarin. |
Assessment & Drug Effects